The global Implantable drug delivery devices market accounted for USD 14.9 Billion in 2020 and is expected to reach USD 26.7 Billion by 2028, growing at a CAGR of around 7.5% between 2021 and 2028.
Market Overview
The global Implantable drug delivery devices market accounted for USD 14.9 Billion in 2020 and is expected to reach USD 26.7 Billion by 2028, growing at a CAGR of around 7.5% between 2021 and 2028.
With the help of implantable drug delivery devices, it has become possible to have site-specific drug delivery. This is of great importance in cardiology and oncology. Implantable drug delivery devices help in the constant release of a therapeutic agent. Implantable drug delivery devices require smaller dosages as compared its counterpart which in turn reduces the probability of side effects from drugs. Implantable drug delivery devices are used in a number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, central nervous system (CNS) health, oncology, contraception, and cardiology.
COVID-19 Impact Analysis
The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year. The global Implantable drug delivery devices market has witnessed a slight decline in the sales for short term to the lockdown enforcement placed by governments in order to contain COVID spreading. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year. The significant decrease in the global Implantable drug delivery devices market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.
Growth Factors
Global implantable drug delivery devices market is primarily driven by growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases. Other major driving factors for growth of implantable drug delivery devices market is rising cases of unwanted pregnancies. However, strict government regulations implied on this industry and the high cost of these devices are major restraints that may curb the growth of the market.
Nonetheless, the introduction of new and more effective implantable drug delivery devices is likely to disclose the new avenues for implantable drug delivery devices market in the near future.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Segment Analysis Preview
The implantable drug delivery devices market is segmented on the basis of different products including drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. In 2020, implantable drugs infusion pumps were the largest segment of implantable drug delivery devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period. Contraceptive drug delivery device is another major product segment of implantable drug delivery devices.
Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others are the key end-user segment of the global implantable drug delivery devices market. The cardiovascular end-user segment dominated the market in terms of revenue. The cardiovascular segment is likely to have a significant growth within the forecast period and is projected to the fastest growing segment as a result of increasing usage of bio-absorbable stents.
Regional Analysis Preview
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global implantable drug delivery devices market. North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2020. Asia Pacific is expected to be the fastest growing region in implantable drug delivery devices market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.
Key Market Players & Competitive Landscape
Some of the major players of the global implantable drug delivery devices market include Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.
The global Implantable drug delivery devices Market is segmented as follows:
By Products
By End-users
By Region
List of Figures
FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End-user
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Implantable drug delivery devices Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 7. Global Implantable drug delivery devices Market for Drug Infusion Pumps, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Infusion Pumps, By Country, 2020 & 2028
FIG NO. 9. Global Implantable drug delivery devices Market for Drug Delivery Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Delivery Devices, By Country, 2020 & 2028
FIG NO. 11. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Implantable drug delivery devices Market for Bio-Absorbable Stents, By Country, 2020 & 2028
FIG NO. 13. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Implantable drug delivery devices Market for Coronary Drug Eluting Stents, By Country, 2020 & 2028
FIG NO. 15. Global Implantable drug delivery devices Market for Brachytherapy Seeds, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Implantable drug delivery devices Market for Brachytherapy Seeds, By Country, 2020 & 2028
FIG NO. 17. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 19. Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, By Country, 2020 & 2028
FIG NO. 21. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 22. Global Implantable drug delivery devices Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Implantable drug delivery devices Market for Oncology, By Country, 2020 & 2028
FIG NO. 24. Global Implantable drug delivery devices Market for Contraception, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraception, By Country, 2020 & 2028
FIG NO. 26. Global Implantable drug delivery devices Market for Cardiovascular, Revenue (USD Billion) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Implantable drug delivery devices Market for Cardiovascular, By Country, 2020 & 2028
FIG NO. 28. Global Implantable drug delivery devices Market for Ophthalmology, Revenue (USD Billion) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Implantable drug delivery devices Market for Ophthalmology, By Country, 2020 & 2028
FIG NO. 30. Global Implantable drug delivery devices Market for Inflammatory Conditions, Revenue (USD Billion) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Implantable drug delivery devices Market for Inflammatory Conditions, By Country, 2020 & 2028
FIG NO. 32. Global Implantable drug delivery devices Market for Diabetes, Revenue (USD Billion) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Implantable drug delivery devices Market for Diabetes, By Country, 2020 & 2028
FIG NO. 34. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Implantable drug delivery devices Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Implantable drug delivery devices Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 38. Porter’s Five Forces Analysis for Global Implantable drug delivery devices Market
FIG NO. 39. PEST Analysis for Global Implantable drug delivery devices Market
FIG NO. 40. Pricing Analysis for Global Implantable drug delivery devices Market
FIG NO. 41. Value Chain Analysis for Global Implantable drug delivery devices Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Bausch & Lomb Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Bausch & Lomb Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
List of Tables
TABLE NO. 1. Global Implantable drug delivery devices Market: Snapshot
TABLE NO. 2. Quarterly Implantable drug delivery devices Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Implantable drug delivery devices Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Implantable drug delivery devices Market for Drug Infusion Pumps, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Implantable drug delivery devices Market for Drug Delivery Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Implantable drug delivery devices Market for Brachytherapy Seeds, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12: Global Implantable drug delivery devices Market for others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Implantable drug delivery devices Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14 Global Implantable drug delivery devices Market for Contraception, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Implantable drug delivery devices Market for Cardiovascular, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Implantable drug delivery devices Market for Ophthalmology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Implantable drug delivery devices Market for Inflammatory Conditions, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Implantable drug delivery devices Market for Diabetes, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Implantable drug delivery devices Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 20. Global Implantable drug delivery devices Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. North America Implantable drug delivery devices Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 22. North America Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 23. North America Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 24. U.S. Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 25. U.S. Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 26. Canada Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 27. Canada Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 28. Mexico Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 29. Mexico Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 30. Drivers for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 31. Restraints for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 32. Major Buyers of Implantable drug delivery devices
TABLE NO. 33. Distributors/Traders List of Implantable drug delivery devices
TABLE NO. 34. Global Implantable drug delivery devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 35: Global Implantable drug delivery devices Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)
This report is based on in-depth qualitative and quantitative analyses of the global Implantable Drug Delivery Devices market. Zion Research has collected and analyzed key data belong to the global Implantable Drug Delivery Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Implantable Drug Delivery Devices across the world has been calculated through primary and secondary research.
Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Implantable Drug Delivery Devices industry. Primary research makes up major source of data collection and validation.
Primary Research
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary Research
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Implantable Drug Delivery Devices market.
Models
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
Implantable drug delivery devices offer multiple advantages over conventional oral or parental drug delivery methods. Implantable drug delivery devices help to provide localized, site-specific drug delivery, which is of great importance in oncology and cardiology, where targeted delivery minimize side effects or damage to healthy tissue and help to improve the effectiveness of treatment. Moreover, the dosage required in implantable drug delivery devices is lower as compared to other modes of drug delivery which in turn lowers the chances of side effects. Implantable drug delivery devices are used in number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, oncology, contraception, cardiology, and central nervous system (CNS) health.
Growing incidences of target disease such as diabetic retinopathy, prostate cancer, cardiovascular diseases and chronic diseases is expected to be the major drivers for the global implantable drug delivery devices market. In addition, growing geriatric population coupled along with rising cases of unwanted pregnancies is expected to trigger the growth of implantable drug delivery devices industry in the coming years. Moreover, increasing demand for minimally invasive procedures coupled along with technological innovations is expected to help implantable drug delivery devices industry steep growth in coming years. However, strict government regulations implied on this industry and high cost of these devices may pose the challenge to implantable drug delivery devices market. Nevertheless, introduction of new and more effective implantable drug delivery devices is expected to act an opportunity for implantable drug delivery devices market in near future.
Based on product, implantable drug delivery devices market has been segmented into drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. Implantable drug delivery devices market was dominated by implantable drugs infusion pumps segment which accounted for largest share across the globe. Further it is expected to continue its dominance over the forecast period.
The implantable drug delivery devices market is segmented into end-user such as oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and other end-users. In terms of demand, the cardiovascular end-user segment dominated the market in 2015. Cardiovascular device is projected to be the fastest growing end-user segment as a result of increasing usage of bio-absorbable stents.
North America is expected to remain the dominant region over the forecast period. The U.S. is world’s largest market for biopharmaceutical. The strongly established pharmaceutical industry in this region offers good growth opportunities for implantable drug delivery devices in this region. Europe was second largest market for implantable drug delivery devices in 2015. Asia Pacific is projected to be the fastest growing region for implantable drug delivery devices market during the forecast period. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.
Some of the key players in Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.
Request the coronavirus impact analysis across industries and markets
The global Implantable drug delivery devices Market was valued at USD 14.9 billion in 2020.
The global Implantable drug delivery devices Market is expected to reach USD 26.7 billion by 2028, growing at a CAGR of 7.5% between 2021 to 2028.
Some of the key factors driving the global Implantable drug delivery devices Market growth is growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases.
North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2020.
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed